Ambrisentan
Brand name: Ambrisentan
Rank #139 of 500 drugs by total cost
$117.7M
Total Cost
23,927
Total Claims
$117.7M
Total Cost
709
Prescribers
$4,917
Cost per Claim
1,006
Beneficiaries
24,586
30-Day Fills
$166K
Avg Cost/Provider
34
Avg Claims/Provider
About Ambrisentan
Ambrisentan (sold as Ambrisentan) was prescribed 23,927 times by 709 Medicare Part D providers in 2023, costing the program $117.7M. At $4,917 per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 136 | Edaravone (Radicava Ors) | $119.6M | 8,588 |
| 137 | Insulin Regular, Human (Afrezza) | $119.4M | 143,017 |
| 138 | Ezetimibe (Ezetimibe) | $118.1M | 2,859,001 |
| 139 | Ambrisentan (Ambrisentan) | $117.7M | 23,927 |
| 140 | Memantine Hcl (Memantine Hcl) | $117.5M | 2,268,098 |
| 141 | Estradiol (Estradiol) | $115.7M | 1,412,386 |
| 142 | Vortioxetine Hydrobromide (Trintellix) | $113.9M | 197,873 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology